# Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - Inspection Records

Source: https://www.keypedia.com/companies/qilu-pharmaceutical-co-ltd-high-tech-zone-site/94263442-b5c4-4df8-b563-30ae0b9a4206

> Inspection records and compliance data for Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) in Jinan, None. Access full analysis and detailed observations.

---

## Details

- Name: Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site)
- FEI Number: 3003802432
- City: Jinan
- State: None
- Country Name: China
- Address Line 1: 317 Xinluo Road, High Tech Zone
- Zip Code: None
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [483 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - Unknown Date](https://www.keypedia.com/records/483/qilu-pharmaceutical-co-ltd-high-tech-zone-site/57f68425-186a-46f7-be58-9d26c4aa513d) — source: FDA, date: Invalid Date
- [483 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - Unknown Date](https://www.keypedia.com/records/483/qilu-pharmaceutical-co-ltd-high-tech-zone-site/d67404c0-879f-4dd4-8407-58d014e644e8) — source: FDA, date: Invalid Date
- [483 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - 2026-06-12](https://www.keypedia.com/records/483/qilu-pharmaceutical-co-ltd-high-tech-zone-site/29452266-732f-432e-a667-3a65447eda2e) — source: FDA, date: June 12, 2026
- [FDA Inspection 1325080 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - 2026-06-12](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-co-ltd-high-tech-zone-site/6d2cc99e-7ff3-4cee-af67-f2bd90c2bd50) — source: FDA, date: June 12, 2026
- [FDA Inspection 1259422 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - 2025-01-14](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-co-ltd-high-tech-zone-site/f9a6df23-bade-43ab-b78c-7af88b45e77f) — source: FDA, date: January 14, 2025
- [FDA Inspection 1259422 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - 2025-01-14](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-co-ltd-high-tech-zone-site/2861e188-d5bb-4db8-8cb0-dff2030e8ff0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 14, 2025
- [483 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - 2024-07-29](https://www.keypedia.com/records/483/qilu-pharmaceutical-co-ltd-high-tech-zone-site/73c7dc58-8862-45e4-aa38-1b97f1768aad) — source: FDA, date: July 29, 2024
- [FDA Inspection 1250164 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - 2024-07-29](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-co-ltd-high-tech-zone-site/b8e4e5e9-17da-445f-8952-dedf8a804bf5) — source: FDA, date: July 29, 2024
- [FDA Inspection 1108992 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - 2019-09-27](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-co-ltd-high-tech-zone-site/abe98b75-db71-4a35-8d7b-a04eeb4ba4eb) — classification: No Action Indicated (NAI), source: FDA, date: September 27, 2019
- [FDA Inspection 1052408 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - 2018-04-17](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-co-ltd-high-tech-zone-site/0c4030f5-64da-4dcd-8d4b-cf94c6774baa) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 17, 2018
- [483 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - 2017-09-20](https://www.keypedia.com/records/483/qilu-pharmaceutical-co-ltd-high-tech-zone-site/3d7aec8f-e0dc-4b88-82af-40bed46c9b2f) — source: FDA, date: September 20, 2017
- [FDA Inspection 1028446 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - 2017-09-20](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-co-ltd-high-tech-zone-site/92c13992-11c8-43d9-a607-1cc46ad0a04e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 20, 2017
- [483 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - 2015-05-19](https://www.keypedia.com/records/483/qilu-pharmaceutical-co-ltd-high-tech-zone-site/537a5a2e-46c6-42b0-a116-3a7c6a18817d) — source: FDA, date: May 19, 2015
- [FDA Inspection 930087 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - 2015-05-19](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-co-ltd-high-tech-zone-site/ce17088f-a5f7-41e3-bb15-ce170041f50c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 19, 2015
- [483 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - 2013-07-18](https://www.keypedia.com/records/483/qilu-pharmaceutical-co-ltd-high-tech-zone-site/4de1de8f-387e-477c-9cb4-ff22defa0cba) — source: FDA, date: July 18, 2013
- [FDA Inspection 841923 - Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) - 2013-07-18](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-co-ltd-high-tech-zone-site/aef658fd-646e-49af-b15a-8d466950a781) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 18, 2013

## Related Companies

- [Jubilant HollisterStier LLC](https://www.keypedia.com/companies/jubilant-hollisterstier-llc/2f8cb6dd-3555-4528-a2d6-d3b845d229ba)
- [NATCO Pharma Limited](https://www.keypedia.com/companies/natco-pharma-limited/4c97e2d8-0023-4572-966f-d396e8fecc05)
- [Emcure Pharmaceuticals Limited](https://www.keypedia.com/companies/emcure-pharmaceuticals-limited/d1295106-bf79-46f5-bf51-08338508f98e)
- [Ipca Laboratories Limited](https://www.keypedia.com/companies/ipca-laboratories-limited/8357cd13-53b4-4e4d-a2a5-54b750096c7a)
- [Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen)](https://www.keypedia.com/companies/vetter-pharma-fertigung-gmbh-co-kg-ravensburg-mooswiesen/d0287c3d-c544-40de-aece-ba713025286c)
- [Ascent Pharmaceuticals Inc](https://www.keypedia.com/companies/ascent-pharmaceuticals-inc/a6df28ee-9e4e-4fae-8eed-dbe5eb870593)
- [Gland Pharma Limited, Units I+II Pashamylaram Site](https://www.keypedia.com/companies/gland-pharma-limited-units-iii-pashamylaram-site/a7dffca3-c5cc-4802-9cab-54995e7133ca)
- [Glenmark Pharmaceuticals Limited](https://www.keypedia.com/companies/glenmark-pharmaceuticals-limited/66c964bb-f670-493b-ab86-aa8507e68a5d)
- [Glenmark Pharmaceuticals Limited](https://www.keypedia.com/companies/glenmark-pharmaceuticals-limited/8a329d32-4a7d-4062-8336-1a4c9455759e)
- [MassBiologics](https://www.keypedia.com/companies/massbiologics/fa584e7c-22de-470c-836a-dd3028fae600)

## Related Officers

- [Research Specialist II](https://www.keypedia.com/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)
- [Chemist at US Department of Health and Human Services](https://www.keypedia.com/people/felix-maldonado/d7a5c4bd-2aa7-405f-b3c4-17ef35152ab4)
- [Santos E. Camara](https://www.keypedia.com/people/santos-e-camara/18cea942-f6f9-4dec-9ce9-1c01c39009ce)
- [Zachary A. Bogorad](https://www.keypedia.com/people/zachary-a-bogorad/ae582dcd-f893-44a5-98bd-0b55f401577b)